Found 19 matching trials
Comparison Among Erythropoietin Stimulating Agents
PHASE4\* Background: Despite extensive use, to the best of our knowledge, no tria...
Location
Fahd Bin Jassem Dialysis Centre
Intracoronary Darbepoetin-alpha to Reduce The Infarct Size and Post-Infarct Remodeling
PHASE2Prospective, randomized and open label trial
Hypothesis
* Infusion of int...
Location
Seoul National University Bundang Hospital
Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)
PHASE2Daprodustat has demonstrated an ability to effectively raise hemoglobin con...
Location
GSK Investigational Site
A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients
NAThis is a prospective single-arm open-labeled cohort study on dialysis pati...
Location
Division of Nephrology, Department of Medicine, Queen Mary Hospital
Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes
PHASE3REGIME is comparing two treatments, with Darbepoetin Alpha (DA) and Filgras...
Location
Birmingham Cancer Research UK Clinical Trial Unit
Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)
PHASE2Myelodysplastic syndromes (MDS) are acquired clonal disorders of the bone m...
Location
St Bartholomew's Hospital
Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)
PHASE2This is an evaluation of the effectiveness of darbepoetin alpha in treating...
R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma
PHASE3This study is a multicentric randomized trial evaluating the efficacy and s...
Location
Université de Gent
Comparison Between Darbapoeitin Alpha and Roxadustat in CKD-related Anemia
N/AAnemia is a common and debilitating complication of end-stage kidney diseas...
Location
Electricity Hospital
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
PHASE3An investigator-blinded, randomized, multicenter, active-controlled Phase I...
Location
"ARABKIR" Joint Medical Center & Institute of Child and Adolescent Health